Intravitreal bevacizumab (Avastin®) for diabetic retinopathy at 24-months: The 2008 Juan Verdaguer-planas lecture

"Diabetic retinopathy (DR) remains the major threat to sight in the working age population. Diabetic macular edema (DME) is a manifestation of DR that produces loss of central vision. Proliferative diabetic retinopathy (PDR) is a major cause of visual loss in diabetic patients. In PDR, the grow...

Descripción completa

Detalles Bibliográficos
Autores Principales: Arevalo J.F., Sanchez J.G., Lasave A.F., Wu L., Maia M., Bonafonte S., Brito M., Alezzandrini A.A., Restrepo N., Berrocal M.H., Saravia M., Farah M.E., Fromow-Guerra J., Morales-Canton V., Espinoza J.V., Aggio F.B., Quiroz-Mercado H., Guerrero-Naranjo J.L., Rodriguez F.J., Infante R., Medina D., Cruz-Villegas V., Graue-Wiechers F., Lozano-Rechy D., Robledo V., Rodriguez-Loaiza J.L., Roca J.A., Reategui G., Saravia M.J., Martinez-Cartier M., Avila M., Cardillo J., Costa R.A., Verdaguer J., Carpentier C., Verdaguer J.I., Filsecker D.L., Sepúlveda G., Sanchez F., Marini C., Garcia B., Pan-American Collaborative Retina Study Group (PACORES)
Formato: Artículo (Article)
Lenguaje:Inglés (English)
Publicado: Bentham Science Publishers B.V. 2010
Materias:
Acceso en línea:https://repository.urosario.edu.co/handle/10336/23801
https://doi.org/10.2174/157339910793360842